View Press Releases
-
Salaso Health’s telemedicine and live exercise platform enable US healthcare teams to stay safely connected with COVID-19 patients
NEW YORK, NY, UNITED STATES - Sep 10, 2020 - In the current pandemic environment, face-to-face physical therapy visits are less viable due to increasing demands on the healthcare system, as well as the enactment of stay-at-home measures and the reticence of patients particularly those from at-risk groups to visit a clinic or hospital setting
Sep 10, 2020
-
Peer-reviewed Study by Optibrium Demonstrates the Value of Deep Learning for Imputation of Drug Discovery Data
CAMBRIDGE, UNITED KINGDOM - Sep 9, 2020 - Optibrium, leading providers of software and services for drug discovery, today announced a peer-reviewed publication, Practical Applications of Deep Learning to Impute Heterogeneous Drug Discovery Data, in the Journal of Chemical Information and Modeling [1]
Sep 10, 2020
-
Dotmatics introduces eln.online to support research start-ups
BISHOP'S STORTFORD, UNITED KINGDOM - Sep 9, 2020 - Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the introduction of eln
Sep 10, 2020
-
Phosplatin Therapeutics Announces Two Leadership Appointments
NEW YORK, NY - Sep 9, 2020 - Phosplatin Therapeutics, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced the addition to its growing team of Joseph F
Sep 9, 2020
-
MDI Biological Laboratory Scientists Decipher Role of a Stress Response Gene
BAR HARBOR, ME, UNITED STATES - Sep 9, 2020 - Scientists have long known that chronic stress experienced early in life, or even chronic prenatal exposure to maternal stress hormones in the womb, can shorten lifespan and contribute to age-related chronic diseases like arthritis, asthma, cancer, cardiovascular disease, diabetes, heart disease and even mental illness later in life -- long after the source of stress has been removed
Sep 9, 2020
-
ECCRT and IDDI establish partnership for continuous development of IDDI global team members
LOUVAIN-LA-NEUVE, BELGIUM - Sep 9, 2020 - European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning by IDDI, a BIOSTATISTICAL AND ECLINICAL SERVICES provider for Pharmaceutical and Biotechnology companies
Sep 9, 2020
-
Lifebit Appoints General Manager to Spearhead Global Expansion
LONDON, UK - Sep 8, 2020 - Lifebit Biotech announced today the appointment of Frank Seo, who joins the company as General Manager
Sep 8, 2020
-
DIASORIN AND MEMED PARTNER TO DEVELOP AND COMMERCIALIZE NOVEL HOST IMMUNE RESPONSE BASED DIAGNOSTICS SOLUTION
SALUGGIA, ITALY AND HAIFA, ISRAEL - Sep 8, 2020 - DiaSorin (FTSE MIB: DIA) and MeMed have announced today the creation of a strategic partnership to accelerate the deployment of a novel, host-protein signature-based assay
Sep 8, 2020
-
First-class Chelating Agents Covering Full Range Are Available at CD Bioparticles
SHIRLEY, NY, UNITED STATES - Sep 9, 2020 - Chelating agents are chemical compounds that react with metal ions to form a stable, water-soluble complex
Sep 6, 2020
-
Creative Biolabs Introduces One-Stop CAR-T Preclinical In Vivo Assay Services
SHIRLEY, NY, UNITED STATES - Sep 7, 2020 - Chimeric antigen receptor (CAR) T cell therapy represents the culmination of research in both immunology and oncology fields
Sep 6, 2020
-
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
BOSTON, MA - Sep 3, 2020 - Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund 2,[1] with participation by existing investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI
Sep 3, 2020
-
Former FDA Commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at CPhI Festival of Pharma
AMSTERDAM, THE NETHERLANDS - Sep 3, 2020 - : CPhI Festival of Pharma (5-16 October, 2020), the worlds largest ever virtual pharma expo, unveils its ground-breaking two-week long agenda
Sep 3, 2020
-
Senior team at healthcare agency Page & Page become Partners
LONDON, UNITED KINGDOM - Sep 2, 2020 - Senior team at healthcare agency Page & Page become Partners Significant changes at Page & Page and Partners also include a new London office, a series of client wins and company growth during Covid London, UKx
Sep 2, 2020
-
AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy Primary tabs
EDINBURGH, UNITED KINGDOM - Sep 2, 2020 - Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage gene therapy company dedicated to developing adeno-associated virus (AAV) gene therapies for genetic disorders, announces the award of a £1
Sep 2, 2020
-
FamHis, Inc. Completes its Launch of the FamGenix Family Health History Platform
BOYNTON BEACH, FL - Sep 1, 2020 - FamHis, Inc. announces the completion and worldwide release of their next-generation family health history platform FamGenix
Sep 1, 2020
-
CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management
LOUVAIN-LA-NUEVE, BELGIUM - Sep 1, 2020 - CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, today announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management
Sep 1, 2020
-
CD Genomics Introduces Extended Panels for SARS-CoV-2 Detection and Research
SHIRLEY, NY, UNITED STATES - Aug 28, 2020 - CD Genomics, a leader in sequencing, microarray analysis, library construction and genotyping, recently announced availability of its CDAMP® SARS-CoV-2 Panel Kit, CDCAP® β-CoVs Panel Kit and CDCAP® Respiratory Virus Panel Kit for SARS-CoV-2 detection and research via its predesigend NGS panels
Aug 27, 2020
-
Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners
PRESTON, UNITED KINGDOM - Aug 26, 2020 - Since launching its first site in Preston in North West England in 2019, Panthera continues to expand its network of UK clinical trial sites with a new site in North London in collaboration with a GP Super partnership Medicus Health Partners
Aug 26, 2020
-
Aveshka announces Dr. Til Jolly as Chief Medical Officer
WASHINGTON, DC, UNITED STATES - Aug 10, 2020 - Aveshka announced Dr. Til Jolly will join the companys executive team in the newly created role of Chief Medical Officer (CMO)
Aug 21, 2020
-
The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry
NY, NY - Aug 19, 2020 - Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management
Aug 20, 2020